Ifp Advisors, Inc Tcr2 Therapeutics Inc. Transaction History

Ifp Advisors, Inc

5 transactions

Quarter	Operation	Price Per share	shares change
Q3 2021 Oct 06, 2021	SELL	$8.44 - $18.35 $0 - $0	0 Closed
Q2 2021 Jul 13, 2021	BUY	$16.41 - $24.71 $0 - $0	0 New
Q1 2021 Apr 30, 2021	BUY	$20.38 - $34.07 $0 - $0	0 New
Q4 2020 Jan 25, 2021	BUY	$19.0 - $32.63 $0 - $0	0 New
Q3 2020 Oct 29, 2020	BUY	$13.1 - $20.69 $0 - $0	0 New

Ticker TCRR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,606,400
Description
TCR2 Therapeutics Inc., a clinical-stage immunotherapy company, focuses on developing novel T cell receptor (TCR) therapies for patients suffering from cancer. The company's lead product candidates include gavo-cel, a mono TCR Fusion Construct T cells (TRuC-T cells) targeting mesothelin positive solid tumors, which is in phase I/II clinical tria...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.